Methods of treating ocular fibrotic pathologies
US-2025170143-A1 · May 29, 2025 · US
US9562030B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9562030-B2 |
| Application number | US-201414778311-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 19, 2014 |
| Priority date | Mar 19, 2013 |
| Publication date | Feb 7, 2017 |
| Grant date | Feb 7, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a process for the synthesis of olopatadine. Further, the invention discloses a process that results in improved yield of the desired Z isomer.
Opening claim text (preview).
We claim: 1. An improved process for synthesis of olopatadine comprising the steps of: a. treating Isoxepac (5), 2-(11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid with thionyl chloride in the ratio ranging between 2 to 4 in the presence of an alcohol at room temperature in the range of 15 to 30° C. for period in the range of 12 to 24 hours to yield the corresponding ester; b. treating the ester of step (a) with allyl bromide using Zn in a solvent conducting Barbier reaction to obtain the allylic alcohol 4; c. Hydroborating the allyl alcohol (4) as obtained in step (b) using 9-BBN (9-Borabicyclo(3.3.1)nonane)/diborane quenched by sodium hydroxide and hydrogen peroxide to obtain diol 6; d. treating diol 6 as obtained in step (c) with catalytic p-toluenesulfonic acid to form a spiro tetrahydrofuran ring 3 in almost quantitative yield; e. treating compound 3 as obtained in step (d) with AlCl 3 as Lewis acid in dichloromethane to yield olefin 2 and satisfactory E/Z ratio of 1 to 1.5; f. subjecting compound 2 of step (e) to mesylation and dimethyl amination to result in compound 7 in the range of 55 to 60%; g. treating compound 7 as obtained in step (f) with aqueous NaOH to yield the corresponding carboxylic acid, treating the acid with p-toluenesulfonic acid to yield the corresponding p-toluenesulfonate, crystallizing the p-toluenesulfonate to isolate the Z-isomer of the p-toluenesulfonate, treating the Z-isomer of the p-toluenesulfonate with NaHCO 3 to yield the free base 8 and treating free base 8 with aqueous HCl to give 1 with E:Z ratio of 1:1.5 2. The process according to claim 1 , wherein the alcohol used in step (a) is methanol. 3. The process according to claim 1 , wherein the solvent used in step (b) is dimethyl formamide (DMF).
[b,e]-condensed · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.